Social Media

🛤️ The #amyloidosis journey is often longer than it should be. For many patients, diagnosis doesn’t happen overnight.For some, this journey takes months. For others…

Hereditary ATTR-CM can be difficult to recognize—but early identification can change the course of care.Stay current with the latest ESC Heart Failure 2026 evidence…

Representation in rare disease care isn’t just about seeing yourself in the room. It changes everything: diagnosis, trust, and follow-through.When Black patients…

 Join us live to explore how ATTR-CM treatment success can be measured in clinical practice.Register here: https://ow.ly/XM8w50ZjBVXThis CME-accredited webinar…

Cardiomyopathy in Focus: Recognizing and Managing Cardiac Amyloidosis

AL amyloidosis can feel overwhelming — but understanding it doesn’t have to be. Join us to learn how the disease is diagnosed, what available treatment options and…

Atrial fibrillation affects up to 70% of patients with ATTR-CM—but how does it impact treatment outcomes?Dr. Brett Sperry and I discuss new findings showing that…

Heart Health Matters: Learn About ATTR-CM (ATTR-Cardiac Amyloidosis) ATTR-CM is a progressive condition caused by a buildup of abnormal proteins in the heart,…

Signs and Symptoms of Transthyretin Amyloid Cardiomyopathy (ATTR-CM). See link below 

Why HFpEF and ATTR-CM need greater visibility in heart failure pathways and policyWe talk a lot about the UK’s heart failure challenge.But less about how we can…